| ￥2520 | |
| Z03821 | |
|
|
|
|
|
|
|
|
|
| Species | Bovine | |
| Protein Construction |
|
|
| Purity | ≥ 95% as analyzed by SDS-PAGE | |
| Endotoxin Level | < 0.2 EU/μg of protein by gel clotting method | |
| Expression System | E.coli | |
| Theoretical Molecular Weight | 20.7 kDa | |
| Apparent Molecular Weight | ~ 20.9 kDa, on SDS-PAGE under reducing conditions | |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS, pH 7.4 | |
| Reconstitution | Before opening, centrifuge the vial briefly to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O up to 100 μg/ml | |
| Storage & Stability | Upon receiving, this product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable up to 1 week at 4 °C or up to 3 months at -20 °C or below. Avoid repeated freeze-thaw cycles. |
»
»
Lane 1: 2 µg of IL-6, Bovine under reducing condition (R)
Lane 2: 2 µg of IL-6, Bovine under non-reducing condition (NR) (N)
The purity is greater than 95% as analyzed by SDS-PAGE
»| Target Background | Interleukin-6 (IL-6), also known as BSF-2, CDF and IFNB2, is a pleiotropic cytokine. IL-6 participates in both pro-inflammatory and anti-inflammatory responses. IL-6 is produced mainly by T cells, macrophages and muscle cells. It stimulates B cell differentiation and antibody production, and cell differentiation. |
| Synonyms | Interleukin-6;IL-6; |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
